Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P L Shcherbakov

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Terapevticheskii Arkhiv|December 6, 2022
[Mesenteric inflammatory veno-occlusive disease is a rare nosological entity: Literature review and the authors' clinical observation]I E Khat'kov, D L Rotin, A I Parfenov, et al.
Terapevticheskii Arkhiv|May 9, 2013
[The role of small bowel microflora in the development of secondary lactase deficiency and the possibilities of its treatment with probiotics]I N Ruchkina, N A Fadeeva, A I Parfenov, et al.
Terapevticheskii Arkhiv|April 1, 2015
[Common variable hypogammaglobulinemia: the author's observation]A I Parfenov, L M Krums, O V Akhmadullina, et al.
Terapevticheskii Arkhiv|April 29, 2014
[Value of adhesion molecules for evaluating the efficiency of therapy for ulcerative colitis and Crohn's disease]A I Parfenov, O N Boldyreva, I N Ruchkina, et al.
Terapevticheskii Arkhiv|September 17, 2016
[Long-term infliximab therapy for ulcerative colitis in real clinical practice]O V Knyazev, A I Parfenov, A V Kagramanova, et al.
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk|July 15, 1998
[Colonic microenvironment in familial helicobacter infection]P L Shcherbakov, A A Vorob'ev, Iu V Nesvizhskiĭ, et al.
Bulletin of Experimental Biology and Medicine|June 21, 2018
Binding of Mucin by E. coli from Human GutT V Vakhrusheva, Yu P Baikova, N G Balabushevich, et al.
Eksperimental'Naia I Klinicheskaia Gastroenterologiia = Experimental & Clinical Gastroenterology|February 28, 2012
[Enterofuril eradication therapy in chronic inflammatory diseases of the upper digestive tract]P L Shcherbakov, O B Ianova, N L Belousova, et al.
Terapevticheskii Arkhiv|April 1, 2016
[Celiac disease detection rate in gastroenterological patients]S V Bykova, E A Sabelnikova, R B Gudkova, et al.
Terapevticheskii Arkhiv|March 11, 2017
[Efficacy of adalimumab for Crohn's disease in real clinical practice]O V Knyazev, A V Kagramanova, I N Ruchkina, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Terapevticheskii Arkhiv|December 6, 2022
[Mesenteric inflammatory veno-occlusive disease is a rare nosological entity: Literature review and the authors' clinical observation]I E Khat'kov, D L Rotin, A I Parfenov, et al.
Terapevticheskii Arkhiv|May 9, 2013
[The role of small bowel microflora in the development of secondary lactase deficiency and the possibilities of its treatment with probiotics]I N Ruchkina, N A Fadeeva, A I Parfenov, et al.
Terapevticheskii Arkhiv|April 1, 2015
[Common variable hypogammaglobulinemia: the author's observation]A I Parfenov, L M Krums, O V Akhmadullina, et al.
Terapevticheskii Arkhiv|April 29, 2014
[Value of adhesion molecules for evaluating the efficiency of therapy for ulcerative colitis and Crohn's disease]A I Parfenov, O N Boldyreva, I N Ruchkina, et al.
Terapevticheskii Arkhiv|September 17, 2016
[Long-term infliximab therapy for ulcerative colitis in real clinical practice]O V Knyazev, A I Parfenov, A V Kagramanova, et al.
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk|July 15, 1998
[Colonic microenvironment in familial helicobacter infection]P L Shcherbakov, A A Vorob'ev, Iu V Nesvizhskiĭ, et al.
Bulletin of Experimental Biology and Medicine|June 21, 2018
Binding of Mucin by E. coli from Human GutT V Vakhrusheva, Yu P Baikova, N G Balabushevich, et al.
Eksperimental'Naia I Klinicheskaia Gastroenterologiia = Experimental & Clinical Gastroenterology|February 28, 2012
[Enterofuril eradication therapy in chronic inflammatory diseases of the upper digestive tract]P L Shcherbakov, O B Ianova, N L Belousova, et al.
Terapevticheskii Arkhiv|April 1, 2016
[Celiac disease detection rate in gastroenterological patients]S V Bykova, E A Sabelnikova, R B Gudkova, et al.
Terapevticheskii Arkhiv|March 11, 2017
[Efficacy of adalimumab for Crohn's disease in real clinical practice]O V Knyazev, A V Kagramanova, I N Ruchkina, et al.
Pageof 8